| Drug Name | (Darzalex®(Daratumumab |
|---|---|
| Drug Class |
Immunosuppressant
|
| Risk minimization type |
Patient Card
|
| Specialty (Theraputic area) |
Oncology
|
| Risk |
Safety information about risk of Interference with blood compatibility testing and Hepatitis B reactivation |
| Patient card |
|
| Health care provider guide |
|
| Dear Healthcare provider letter DHPC |
|